Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case report

Podobne zapisy

• Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorder
  od: Brar, Rupinder, i wsp.
  Wydane: (2019)
• HIV TREATMENT INITIATION AND RETENTION AMONG INDIVIDUALS INITIATED ON INJECTABLE OPIOID AGONIST THERAPY FOR SEVERE OPIOID USE DISORDER: A CASE SERIES
  od: Giang, Valerie, i wsp.
  Wydane: (2020)
• HOSPITAL INITIATED INJECTABLE OPIOID AGONIST THERAPY FOR THE TREATMENT OF SEVERE OPIOID USE DISORDER
  od: Brar, Rupinder, i wsp.
  Wydane: (2021)
• Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach
  od: Caulfield, Mackenzie Duncan Gregory, i wsp.
  Wydane: (2020)
• USE OF A NOVEL PRESCRIBING APPROACH FOR THE TREATMENT OF OPIOID USE DISORDER: BUPRENORPHINE/NALOXONE MICRO-DOSING – A CASE SERIES
  od: Brar, Rupinder, i wsp.
  Wydane: (2020)